Amalia Gastaldelli
#131,810
Most Influential Person Now
Researcher
Amalia Gastaldelli's AcademicInfluence.com Rankings
Amalia Gastaldellicomputer-science Degrees
Computer Science
#5834
World Rank
#6157
Historical Rank
Computational Linguistics
#895
World Rank
#908
Historical Rank
Machine Learning
#1695
World Rank
#1717
Historical Rank
Artificial Intelligence
#1932
World Rank
#1965
Historical Rank
Download Badge
Computer Science
Amalia Gastaldelli's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Amalia Gastaldelli Influential?
(Suggest an Edit or Addition)Amalia Gastaldelli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. (2016) (1859)
- Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. (1993) (1699)
- A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. (2006) (1610)
- Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005) (652)
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease (2013) (634)
- Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. (2007) (528)
- A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. (2003) (492)
- beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. (2005) (491)
- Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. (2008) (416)
- Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. (2005) (403)
- Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients (2008) (388)
- Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis (2011) (359)
- Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population (2009) (357)
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease (2012) (347)
- Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study (2003) (326)
- The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis (2015) (323)
- Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. (2000) (312)
- Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. (2002) (296)
- Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes (2010) (270)
- Metabolic effects of visceral fat accumulation in type 2 diabetes. (2002) (253)
- Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function (2004) (250)
- Hyperinsulinemia and Autonomic Nervous System Dysfunction in Obesity: Effects of Weight Loss (2001) (247)
- AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. (2017) (243)
- Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis (2009) (240)
- Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. (2002) (239)
- Gastric bypass and banding equally improve insulin sensitivity and β cell function. (2012) (238)
- Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance (2018) (230)
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars (2018) (230)
- Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. (2014) (210)
- Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study (2017) (206)
- A new correction factor for use in tracer estimations of plasma fatty acid oxidation. (1995) (206)
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (2016) (205)
- Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. (2006) (198)
- Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes (2011) (197)
- From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options (2019) (181)
- Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. (2004) (173)
- Regulation of plasma fatty acid oxidation during low- and high-intensity exercise. (1997) (170)
- Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C (2009) (168)
- Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. (2007) (167)
- An accurate and robust method for unsupervised assessment of abdominal fat by MRI (2004) (165)
- Ectopic fat and cardiovascular disease: what is the link? (2010) (158)
- Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats (2009) (157)
- Pancreatic islet amyloidosis, β-cell apoptosis, and α-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons (2009) (155)
- Autonomic and hemodynamic responses to insulin in lean and obese humans. (1998) (149)
- Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. (2001) (141)
- beta-cell function in obesity: effects of weight loss. (2004) (136)
- Thiazolidinediones improve beta-cell function in type 2 diabetic patients. (2007) (132)
- Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus. (2011) (126)
- Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. (2011) (125)
- Pathophysiology of Non Alcoholic Fatty Liver Disease (2016) (125)
- Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat (2008) (122)
- Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance (2014) (122)
- Fatty liver index, gamma‐glutamyltransferase, and early carotid plaques (2012) (121)
- Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women (2011) (117)
- Fat metabolism during high-intensity exercise in endurance-trained and untrained men. (2000) (116)
- Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance (2003) (115)
- Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. (2011) (115)
- Direct effect of GLP-1 infusion on endogenous glucose production in humans (2012) (114)
- Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. (2004) (110)
- Pioglitazone in the treatment of NASH: the role of adiponectin (2010) (109)
- Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. (2000) (109)
- Impact of increased visceral and cardiac fat on cardiometabolic risk and disease (2012) (107)
- Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms (2015) (105)
- Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. (2014) (104)
- beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss. (2005) (102)
- The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice*1 (2009) (102)
- Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver (2013) (101)
- Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. (2007) (101)
- Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. (1999) (99)
- Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. (2012) (99)
- Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests (2021) (99)
- Pathway of free fatty acid oxidation in human subjects. Implications for tracer studies. (1995) (98)
- Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training (2007) (94)
- Crosstalk between adipose tissue insulin resistance and liver macrophages in Non Alcoholic Fatty Liver Disease. (2019) (92)
- Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease (2016) (91)
- Long-Term Effects of Bariatric Surgery on Meal Disposal and β-Cell Function in Diabetic and Nondiabetic Patients (2013) (90)
- Effect of acute hyperglycemia on insulin secretion in humans. (2002) (90)
- Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. (2011) (90)
- Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. (1999) (89)
- Glucose kinetics during high-intensity exercise in endurance-trained and untrained humans. (1995) (89)
- Accurate segmentation of subcutaneous and intermuscular adipose tissue from MR images of the thigh (2009) (86)
- Pathophysiology of prediabetes. (2011) (86)
- Thiazolidinediones improve -cell function in type 2 diabetic patients (2007) (85)
- The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention. (2008) (84)
- The Effect of Pioglitazone on the Liver (2006) (83)
- Reduction in Hematocrit and Hemoglobin Following Pioglitazone Treatment is not Hemodilutional in Type II Diabetes Mellitus (2007) (82)
- Prevention of Diabetes With Pioglitazone in ACT NOW (2013) (82)
- Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. (2007) (81)
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. (2021) (80)
- Insulin prolongs the QTc interval in humans. (2000) (79)
- Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes (2017) (79)
- HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH (2014) (78)
- Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study (2017) (78)
- Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients (2007) (77)
- Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms. (2009) (75)
- Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD? (2017) (74)
- Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population (2012) (74)
- Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. (2007) (72)
- The effect of rosiglitazone on the liver: decreased gluconeogenesis in patients with type 2 diabetes. (2006) (71)
- Protein synthesis and breakdown in skin and muscle: a leg model of amino acid kinetics. (1994) (70)
- Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. (2007) (68)
- Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study (2016) (68)
- Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial. (2010) (67)
- Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study (2013) (66)
- Energy expenditure of swimmers during high volume training. (1997) (65)
- Why does obesity cause diabetes? (2022) (64)
- Effects of Probiotic Supplementation on Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial (2020) (62)
- A model for glucose control of insulin secretion during 24 h of free living. (2001) (61)
- Effects of adding exercise to a 16-week very low-calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients. (2012) (61)
- Assessment of methods for improving tracer estimation of non-steady-state rate of appearance. (1999) (61)
- Glucokinase links Krüppel‐like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease (2012) (60)
- Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. (2013) (60)
- Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis (2019) (60)
- Ectopic fat: the true culprit linking obesity and cardiovascular disease? (2013) (58)
- Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk (2013) (56)
- Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes (2007) (56)
- Reply to Comment on: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 43:31–39 (2004) (56)
- Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. (2022) (55)
- Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease (2016) (54)
- Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes (2020) (54)
- Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies (2017) (52)
- Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications (2020) (52)
- Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes (2012) (52)
- Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. (2012) (52)
- Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (2017) (52)
- Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2017) (52)
- Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT. (2013) (51)
- Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non‐insulin‐dependent diabetes (1997) (51)
- Visceral fat and beta cell function in non-diabetic humans (2005) (51)
- Effect of theophylline on substrate metabolism during exercise. (1996) (50)
- Influence of duration of obesity on the insulin resistance of obese non-diabetic patients (1998) (50)
- Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease. (2020) (49)
- Increased FNDC5/Irisin expression in human hepatocellular carcinoma (2017) (49)
- Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects. (2011) (48)
- Matched weight loss induced by sleeve gastrectomy or gastric bypass similarly improves metabolic function in obese subjects (2014) (48)
- What is the role of the receptor for advanced glycation end products–ligand axis in liver injury? (2011) (47)
- Lipid and Carbohydrate Metabolism in IDDM During Moderate and Intense Exercise (1995) (47)
- Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases (2015) (47)
- Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis. (2003) (45)
- Determinants of postabsorptive endogenous glucose output in non-diabetic subjects (2000) (45)
- 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study. (2006) (44)
- Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System (2015) (44)
- Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease (2021) (43)
- Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic (2014) (43)
- Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes (2019) (42)
- Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes (2017) (42)
- Women-specific predictors of cardiovascular disease risk - new paradigms. (2019) (41)
- Abdominal fat: does it predict the development of type 2 diabetes? (2008) (39)
- Determination of the enrichment of the hydrogen bound to carbon 5 of glucose on 2H2O administration. (2001) (38)
- Coordinated Defects in Hepatic Long Chain Fatty Acid Metabolism and Triglyceride Accumulation Contribute to Insulin Resistance in Non-Human Primates (2011) (38)
- Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk (2008) (37)
- Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow‐up (2017) (37)
- Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons (2009) (37)
- Fatty liver disease: the hepatic manifestation of metabolic syndrome (2010) (36)
- Insulin resistance, adipose depots and gut: interactions and pathological implications. (2010) (35)
- Imaging cardiac fat. (2013) (35)
- Vitamin D Supplementation in Patients With Type 2 Diabetes: The Vitamin D for Established Type 2 Diabetes (DDM2) Study (2018) (34)
- Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome (2006) (33)
- Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass (2016) (33)
- Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic risk. (2010) (33)
- Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1. (2016) (33)
- Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance (2020) (31)
- Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity (2013) (30)
- A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis (2013) (29)
- The good and bad effects of statins on insulin sensitivity and secretion (2014) (29)
- Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH (2020) (29)
- PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH (2021) (29)
- Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients. (2009) (29)
- Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk. (2013) (28)
- Time for Glucagon like peptide-1 receptor agonists treatment for patients with NAFLD? (2016) (28)
- The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazone. (2014) (28)
- Protective role of adiponectin on endothelial dysfunction induced by AGEs: a clinical and experimental approach. (2011) (27)
- Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide. (2005) (26)
- Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. (2009) (26)
- Automatic correction of intensity inhomogeneities improves unsupervised assessment of abdominal fat by MRI (2008) (26)
- Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests. (2005) (26)
- Mitochondrial respiratory states and rates (2019) (25)
- Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial. (2021) (24)
- The effect of chronic twice daily exenatide treatment on β‐cell function in new onset type 2 diabetes (2014) (24)
- Peripheral insulin resistance and impaired insulin signaling contribute to abnormal glucose metabolism in preterm baboons. (2015) (23)
- Regulation of glucose production during exercise at 80% of VO2peak in untrained humans. (1997) (23)
- The role of cardiac fat in insulin resistance (2012) (23)
- The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF (2018) (23)
- Insulin: The master regulator of glucose metabolism. (2022) (23)
- Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy. (2013) (23)
- Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity (2019) (23)
- Elevated Concentrations of Liver Enzymes and Ferritin Identify a New Phenotype of Insulin Resistance: Effect of Weight Loss After Gastric Banding (2009) (22)
- Ectopic fat storage, insulin resistance, and hypertension. (2011) (22)
- Interaction of GLP-1 and Ghrelin on Glucose Tolerance in Healthy Humans (2018) (22)
- The ontogeny of the endocrine pancreas in the fetal/newborn baboon. (2012) (21)
- An extended fatty liver index to predict non-alcoholic fatty liver disease. (2017) (21)
- Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study (2018) (21)
- Metabolic dysfunction-associated fatty liver disease: a year in review (2022) (20)
- Glucose kinetics in interstitial fluid can be predicted by compartmental modeling. (1997) (20)
- Effects of sitagliptin on ectopic fat contents and glucose metabolism in type 2 diabetic patients with fatty liver: A pilot study (2014) (20)
- Hepatic and cardiac steatosis: are they coupled? (2012) (20)
- Effects of acute alpha 2-blockade on insulin action and secretion in humans. (1998) (20)
- Increased carotid intima-media thickness in the physiologic range is associated with impaired postprandial glucose metabolism, insulin resistance and beta cell dysfunction. (2013) (20)
- Model-based assessment of insulin sensitivity of glucose disposal and endogenous glucose production from double-tracer oral glucose tolerance test (2008) (19)
- Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P (2020) (19)
- Effect of Oral Sebacic Acid on Postprandial Glycemia, Insulinemia, and Glucose Rate of Appearance in Type 2 Diabetes (2010) (19)
- Metabolic response to high-carbohydrate and low-carbohydrate meals in a nonhuman primate model. (2013) (19)
- Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population? (2020) (19)
- Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models. (2012) (18)
- The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle glucose uptake (2019) (18)
- [11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia. (2006) (17)
- Biomonitoring of Bis(2-ethylhexyl)phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project. (2020) (17)
- Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD. (2020) (17)
- Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant. (2015) (17)
- Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research (2018) (17)
- Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects. (2019) (17)
- Insulin sensitivity depends on the route of glucose administration (2020) (16)
- Relationship between hepatic and systemic angiopoietin‐like 3, hepatic Vitamin D receptor expression and NAFLD in obesity (2020) (16)
- Metabolic, reproductive and thyroid effects of Bis(2-ethylhexyl) phthalate (DEHP) orally administered to male and female juvenile rats at dose levels derived from children biomonitoring study. (2020) (15)
- External Validation of Surrogate Indices of Fatty Liver in the General Population: The Bagnacavallo Study (2021) (15)
- Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: a "non-invasive alternative" to liver biopsy? (2019) (15)
- Inflammatory Biomarkers are Correlated with Some Forms of Regressive Autism Spectrum Disorder (2019) (15)
- Glucose kinetics: an update and novel insights into its regulation by glucagon and GLP-1 (2017) (15)
- Beta‐cell sensitivity to glucose is impaired after gastric bypass surgery (2018) (15)
- Fatty liver, cardiometabolic disease and mortality. (2019) (15)
- Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women (2014) (15)
- The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes. (2020) (15)
- The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases (2018) (14)
- Evidence from a single individual that increased plasma GLP-1 and GLP-1-stimulated insulin secretion after gastric bypass are independent of foregut exclusion (2014) (14)
- Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase (2020) (14)
- Krill Oil Supplementation Reduces Exacerbated Hepatic Steatosis Induced by Thermoneutral Housing in Mice with Diet-Induced Obesity (2021) (14)
- ORIGINAL ARTICLE: Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican‐American patients with Type 2 diabetes: a double tracer OGTT study (2010) (14)
- Metabolic effects of muraglitazar in type 2 diabetic subjects (2011) (14)
- Toxicological Assessment of Oral Co-Exposure to Bisphenol A (BPA) and Bis(2-ethylhexyl) Phthalate (DEHP) in Juvenile Rats at Environmentally Relevant Dose Levels: Evaluation of the Synergic, Additive or Antagonistic Effects (2021) (14)
- Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß‐cell function in non‐diabetic, morbidly obese patients (2017) (14)
- Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas (2019) (13)
- Older Subjects With &bgr;-Cell Dysfunction Have an Accentuated Incretin Release (2018) (13)
- The PNPLA3‐I148M variant increases polyunsaturated triglycerides in human adipose tissue (2020) (13)
- Moving Medical Semeiotics to the Digital Realm - SEMEOTICONS Approach to Face Signs of Cardiometabolic Risk (2014) (13)
- Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease (2019) (13)
- Phthalates Exposure as Determinant of Albuminuria in Subjects With Type 2 Diabetes: A Cross-Sectional Study. (2018) (13)
- Liver-targeting drugs and their effect on blood glucose and hepatic lipids (2021) (12)
- Aleglitazar, a dual peroxisome proliferator‐activated receptor‐α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double‐blind trial (2016) (12)
- Early effect of Roux-en-Y gastric bypass on insulin sensitivity and signaling. (2016) (12)
- Small intestinal metabolism is central to whole-body insulin resistance (2020) (12)
- Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes. (2013) (12)
- The color of fat and its central role in the development and progression of metabolic diseases (2017) (12)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Exenatide regulates pancreatic islet integrity and insulin sensitivity in baboons. (2019) (11)
- Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition (2020) (11)
- Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion (2020) (11)
- Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial. (2021) (10)
- Modeling interpretation of microbe metabolism detected by nuclear magnetic resonance. (1996) (10)
- Beta-cell sensitivity to insulinotropic gut hormones is reduced after gastric bypass surgery (2019) (10)
- Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects (2017) (10)
- Kinetic analysis and comparison of models of xylose metabolism by Klebsiella planticola. (1996) (10)
- Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW (2014) (10)
- Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non‐alcoholic steatohepatitis (2021) (10)
- Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD (2021) (9)
- Albiglutide for the treatment of type 2 diabetes. (2014) (9)
- A direct comparison of long‐ and short‐acting GLP‐1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment (2014) (9)
- Adipose tissue dysfunction and visceral fat are associated to hepatic insulin resistance and severity of NASH even in lean individuals (2022) (9)
- Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance (2021) (9)
- Imaging and laboratory biomarkers in cardiovascular disease. (2009) (9)
- Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance and Insulin Sensitivity in Healthy Glucose Tolerant Subjects. (2020) (9)
- Glucose uptake saturation explains glucose kinetics profiles measured by different tests. (2016) (8)
- Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease (2022) (8)
- New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms (2021) (8)
- Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. (2021) (8)
- Lack of NLRP3-Inflammasome Leads to Gut-Liver AXIS Derangement and Increases Hepatic Injury in a Mouse Model of Non-Alcoholic Fatty Liver Disease (2016) (8)
- Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD (2020) (8)
- Hepatic Insulin Resistance and Altered Gluconeogenic Pathway in Premature Baboons (2017) (7)
- A modellistic view of the kinetics of metabolic processes: differences in the glucose and xylose degradation pathway (1999) (7)
- SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: a randomized clinical trial. (2020) (7)
- Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (2017) (7)
- The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo (2015) (7)
- Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity (2019) (7)
- Linear and Nonlinear Properties of Heart Rate Variability: Influence of Obesity (1999) (6)
- Diet and Exercise in the Treatment of Fatty Liver (2011) (6)
- Biomarkers of exposure and early effect in three contaminated sites of southern Italy: protocols for etiological epidemiological studies (2020) (6)
- Diabetes and Nonalcoholic Fatty Liver Disease (2011) (6)
- Ectopic fat: a target for cardiometabolic risk management (2016) (6)
- Comment on Piccinini and Bergman. The Measurement of Insulin Clearance. Diabetes Care 2020;43:2296–2302 (2020) (5)
- Role of vagal activation in postprandial glucose metabolism after gastric bypass in individuals with and without hypoglycaemia (2019) (5)
- Mechanisms for increased risk of diabetes in chronic liver diseases (2020) (5)
- Motor Activity in Aging: An Integrated Approach for Better Quality of Life (2014) (5)
- A model for assessing insulin secretion and its control under free-living conditions. (2001) (5)
- Pathophysiology of Prediabetes: Role of Lipotoxicity? (2014) (5)
- Italian Children Exposure to Bisphenol A: Biomonitoring Data from the LIFE PERSUADED Project (2021) (5)
- Assessment of Exposure to Di-(2-ethylhexyl) Phthalate (DEHP) Metabolites and Bisphenol A (BPA) and Its Importance for the Prevention of Cardiometabolic Diseases (2022) (4)
- Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. (2022) (4)
- Changes in Plasma Bioactive Lipids and Inflammatory Markers during a Half-Marathon in Trained Athletes (2021) (4)
- Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma. (2020) (4)
- Impact of percent body fat on oral glucose tolerance testing: A cross-sectional study in 1512 obese children (2012) (4)
- Publisher Correction: Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2018) (4)
- Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy. (2022) (4)
- Triglyceride-Induced Diabetes Associated Wi t h Familial Lipoprotein Lipase Defic i e n c y (1999) (4)
- Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic insulin resistance and hepatic fat content (2005) (4)
- COVID-19 Infection Pandemic: From the Frontline in Italy (2020) (4)
- Visceral Adipose Tissue and Ectopic Fat Deposition (2014) (4)
- Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction. (2022) (4)
- 35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
- Bile acid composition modulates insulin resistance in non-diabetic patients with NAFLD (2018) (3)
- Insulin Clearance in Health and Disease. (2022) (3)
- Healthy aging: the INTECMAN project (2020) (3)
- NAFLD and Insulin Resistance: A Multisystemic Disease (2020) (3)
- Effects of acute a2-blockade on insulin action and secretion in humans (1998) (3)
- Angiopoietin-Like4 is Associated with Lipid Metabolism and Severe Fibrosis in Non-Diabetic Patients with Non-Alcoholic Fatty Liver Disease (2016) (3)
- Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT) (2022) (3)
- Effect of Tirzepatide Versus Insulin Degludec on Liver Fat Content and Abdominal Adipose Tissue in Patients with Type 2 Diabetes (SURPASS-3 MRI) (2023) (3)
- Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician. (2019) (3)
- Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose. (2022) (3)
- 1290 THE EFFECT OF EXERCISE ON THE METABOLIC AND HISTOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE (2012) (3)
- Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease (2016) (2)
- Modeling interpretation of microbe metabolism monitored by Nuclear Magnetic Resonance spectroscopy (1996) (2)
- Pathway of Free Fatty Acid Oxidation (1994) (2)
- Beneficial Effects of RYGB on ß-Cell Function and Hepatic and Peripheral Insulin Sensitivity Are Maintained Seven Years after Surgery in Both Diabetic and Nondiabetic Subjects (2018) (2)
- Alteration in lipid metabolism after an oral fat load in subjects with NAFLD. (2013) (2)
- The Disposition Index Does Not Reflect (cid:2) -Cell Function in IGT Subjects Treated With Pioglitazone (2014) (2)
- Mechanism of Action of Inhaled Insulin on Whole Body Glucose Metabolism in Subjects with Type 2 Diabetes Mellitus (2019) (2)
- LIPID METABOLISM DURING HIGH INTENSITY EXERCISE IN ENDURANCE-TRAINED AND UNTRAINED SUBJECTS: 573 (1995) (2)
- Altered Insulin Clearance after Gastric Bypass and Sleeve Gastrectomy in the Fasting and Prandial Conditions (2022) (2)
- FATTY ACID UPTAKE BY THE MITOCHONDRIA LIMITS FAT OXIDATION IN STRENUOUS EXERCISE: 574 (1995) (2)
- Advanced glycation end products, leukocyte telomere length, and mitochondrial DNA copy number in patients with coronary artery disease and alterations of glucose homeostasis: From the GENOCOR study. (2022) (2)
- Genetic variation in PNPLA 3 ( adiponutrin ) confers sensitivity to weight loss – induced decrease in liver fat in humans 1 – 3 (2011) (2)
- 55 METABOLIC AND ANTI-INFLAMMATORY BENEFICIAL EFFECTS OF PIOGLITAZONE (PIO) TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND THEIR ASSOCIATIONS WITH HISTOLOGICAL IMPROVEMENT (2009) (2)
- Measuring and estimating insulin resistance in clinical and research settings (2022) (2)
- Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp. (2018) (2)
- Brown versus white fat: are they really playing a role in obesity and cardiometabolic risk? (2015) (1)
- Evaluation of Published Clinical Scores for the Prediction of Cardiometabolic Risk in the SEMEOTICONS Project (2014) (1)
- Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk (2020) (1)
- Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk (2020) (1)
- Association of serum lipids with β-cell function in obese children and adolescents (2019) (1)
- 1365 METABOLIC ALTERATIONS OF LIPID KINETICS IN NAFLD PATIENTS AND THEIR CONTRIBUTION TO LIVER DAMAGE (2013) (1)
- Postprandial GLP-1 Response Is Inversely Associated with Liver Fat (2009) (1)
- Risk Relationship between Insulin Resistance, Diabetes, and Atherosclerotic Cardiovascular Disease (2014) (1)
- Increased hepatic glucose production and insulin resistance are associated to increased plasma concentrations of glucogenic amino acids in subjects with NAFLD (2017) (1)
- 245-OR: Glucose Production and Utilization following Oral Glucose Load in Type 2 Diabetes Patients Treated with Dapagliflozin Alone and in Saxagliptin Combination (2019) (1)
- 82 KRUPPEL LIKE FACTOR 6 (KLF6) REGULATES HEAPTIC INSULIN RESISTANCE (HEP-IR) (2010) (1)
- Disparity-filtered differential correlation network analysis: a case study on CRC metabolomics (2021) (1)
- Neurophysiological and Behavioural Variables in Cognitive Impairment: Towards a Personalised Monitoring System (2015) (1)
- The independent effect of exercise on the metabolic and histological features of non-alcoholic fatty liver disease (2012) (1)
- A new approach to study in vivo cellular metabolism using a modellistic analysis of magnetic resonance spectra. (2009) (1)
- Relationships between Glucose Clearance during an OGTT and a Euglycemic Clamp (2010) (1)
- An extra virgin olive oil‐enriched chocolate spread positively modulates insulin‐resistance markers compared with a palm oil‐enriched one in healthy young adults: A double‐blind, cross‐over, randomised controlled trial (2021) (1)
- Is it necessary to target lipid metabolism in different organs for effective treatment of NASH?-the results of the Pan-PPAR Lanifibranor trial. (2022) (1)
- Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile. (2015) (1)
- European Obesity Summit (EOS) – Joint Congress of EASO and IFSO-EC, Gothenburg, Sweden, June 1 – 4, 2016: Abstracts (2016) (1)
- Pathogenesis of Diabetes Mellitus type 2 (2009) (1)
- Lack of NLRP3-inflammasome leads to gut-liver axis derangement and increases hepatic injury in a mouse model of NAFLD (2016) (1)
- Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes (2022) (1)
- Analysis of double-tracer glucose kinetics in humans during oral glucose tolerance test (2006) (1)
- Metabolite Changes After Metabolic Surgery – Associations to Parameters Reflecting Glucose Homeostasis and Lipid Levels (2021) (1)
- Assessment of exposure to Di (2-ethylhexyl) phthalate (DEHP) metabolites and Bisphenol A (BPA) and its importance for the prevention of cardiometabolic diseases (2021) (1)
- [Bariatric surgery as a treatment of type 2 diabetes]. (2011) (1)
- The Pro12Ala polymorphism of PPARγ2 modulates beta cell function and failure to oral glucose‐lowering drugs in patients with type 2 diabetes (2020) (1)
- P840 ALTERATION IN LIPID METABOLISM AFTER AN ORAL FAT LOAD IN PATIENTS WITH NAFLD (2014) (0)
- Pacing induced myocardial ischemia in patients with dilated cardiomyopathy. (2005) (0)
- Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease (2019) (0)
- 341 PREVALENCE OF TRANSAMINASE ABNORMALITIES IN GENERAL POPULATION IN XXI CENTURY: THE BAGNACAVALLO STUDY (2010) (0)
- Autoantibodies Against the Glial Glutamate Transporter GLT1/EAAT2 in Type 1 Diabetes Mellitus. Clues to novel immunological and non-immunological therapies. (2022) (0)
- Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and chronic hepatitis C. (2008) (0)
- Splanchnic and liver glucose metabolism : an insulin dose-response study (2006) (0)
- 155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion (2019) (0)
- 1888-P: Impaired Insulin Clearance Relates to Increased Liver Fat Content in Recent-Onset Type 2 Diabetes and to Impaired Glucose Control in Recent-Onset Type 1 Diabetes (2019) (0)
- PS-023 – The combination of mucus-degrading gram-negative bacteria and reduced antimicrobial peptides drives adipose tissue inflammation and non-alcoholic fatty liver disease progression in mice lacking NLRP3-inflammasome (2017) (0)
- Assessment of insulin-glucose uptake dose-response characteristics in the non-steady state (1998) (0)
- Augmented nitric oxide release in the coronary circulation parallels myocardial metabolic stress in patients with dilated cardiomyopathy. (2006) (0)
- Relationship between muscle/adipose tissue morphology, insulin sensitivity and beta cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2014) (0)
- Lean Subjects with Fatty Liver Show Decreased GLP-1 and GIP Response during OGTT (2018) (0)
- Publisher Correction: Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2018) (0)
- Author response for "Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes" (2019) (0)
- Sporadic Colorectal Cancer: An Infectious Disease? (2007) (0)
- FRI-283-Impact on NAFLD of long-term weight loss after bariatric surgery (2019) (0)
- Validation of Tracer Estimations of Plasma Free Fatty Acid Oxidation (1994) (0)
- Relationship between endogenous glucose production and insulin sensitivity in humans. (1999) (0)
- 36 FATTY LIVER INDEX IS ASSOCIATED WITH INCREASED INSULIN RESISTANCE AND CAROTID INTIMA MEDIA THICKNESS (IMT) IN NONDIABETIC SUBJECTS: THE RISC STUDY (2008) (0)
- Evaluation of Metabolic Parameters of Hepatic Dysfunction in Subjects with Hepatocellular Carcinoma and their Change after Liver Transplantation: A Metabolomic Approach (2016) (0)
- , Marco idiopathic dilated cardiomyopathy selection flexibility during stress in patients with Impaired myocardial metabolic reserve and substrate (2007) (0)
- 842 PREDISPOSITION TO DEVELOP DIABETES IN SUBJECTS WITH NAFLD IS RELATED TO INSULIN RESISTANCE RATHER THAN TO DECREASED B-CELL FUNCTION (2011) (0)
- 340 FATTY LIVER INDEX (FLI) IS AN INDEPENDENT PREDICTOR OF CHANGES IN METABOLIC AND CARDIOVASCULAR PARAMETERS: RESULTS FROM A 3-YEAR FOLLOW UP IN THE RISC STUDY (2010) (0)
- Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (2017) (0)
- External validation of biomarkers of fatty liver in the general population: the Bagnacavallo study (2020) (0)
- PS-006-MBOAT7 downregulation induces hepatic lipid accumulation (2019) (0)
- "The Times They Are A-Changin'" at Diabetes Care. (2022) (0)
- 502 Beta cell function (insulin secretion) is impaired in patients with stable chronic heart failure (2004) (0)
- Exenatide Exerts Its Positive Effects on Liver by Reducing both Hepatic and Adipose Tissue Insulin Resistance (2016) (0)
- 346 INCREASED LIVER EXPRESSION OF INFLAMMATORY MEDIATORS IS ASSOCIATED WITH HEPATIC INSULIN RESISTANCE IN LEAN, NON-DIABETIC PATIENTS WITH CHRONIC HEPATITIS C (2009) (0)
- O064 : Gut-liver axis derangement due to lack of inflammasome activity leads to visceral obesity and nash development (2015) (0)
- A Model for Assessing Insulin Secretion Function During a 24 Hour Standardized Life Period (2000) (0)
- Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery (2017) (0)
- Predictive Models of Insulin Resistance Derived from Simple Morphometric and Metabolic Measurements Related to Obesity in Baboons. (2008) (0)
- Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease (2020) (0)
- OC-07A machine learning approach for the classification of NASH vs NAFL in diabetic and non-diabetic subjects reveals a strong association between liver inflammation and adipose tissue dysfunction (2021) (0)
- The assessment of glucose appearance rate and hepatic glucose uptake by [18F]fluorodeoxyglucose : validation against 6,6-2H-glucose (2005) (0)
- Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation (2016) (0)
- metabolism: a non-steady-state approach Dose-response characteristics of insulin action on glucose (2013) (0)
- Adipose tissue insulin resistance and inflammation, but not reduced hepatic fat oxidation, are associated to active NASH and severe fibrosis (2020) (0)
- Time for GLP-1 RA treatment for patients with NAFLD ? (2015) (0)
- Editorial: Mechanisms for the Alteration in the Crosstalk Among Insulin-Sensitive Tissues (2022) (0)
- 360-OR: Hyperglucagonemia Reduces De Novo Lipogenesis and Increases Gluconeogenesis in Healthy Subjects (2022) (0)
- 1310 PERIPHERAL INSULIN RESISTANCE RATHER THAN HEPATIC IS A PRIMARY DEFECT IN NON OBESE, NON DIABETIC, NON DYSLIPIDEMIC NAFLD PATIENTS: CORRELATION WITH LIVER DAMAGE (2012) (0)
- Reply: (2009) (0)
- Exposure to Endocrine Disruptors (Di(2-Ethylhexyl)phthalate (DEHP) and Bisphenol A (BPA)) in Women from Different Residing Areas in Italy: Data from the LIFE PERSUADED Project (2022) (0)
- Gut–liver axis derangement due to lack of inflammasome activity leads to visceral obesity and NASH development (2015) (0)
- Impaired glucose tolerance exacerbates the abnormal myocardial metabolic response to pacing in subjects with dilated cardiomyopathy (2008) (0)
- Study of inflammations' markers and insulin resistance in obese children and adolescents with and without non-alcoholic fatty liver disease. (2009) (0)
- Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease (2016) (0)
- P843 ALTERATION IN GLUCOSE METABOLISM AFTER AN ORAL GLUCOSE LOAD AND RELATIONSHIP WITH LIVER DAMAGE IN PATIENTS WITH NAFLD (2014) (0)
- Exenatide Increases Glucose Uptake in Brain Areas Involved in Glucose Homeostasis and Food Intake (2014) (0)
- Minutes of the 24th General Assembly of the European Association for the Study of Diabetes (2004) (0)
- Upregulating Heme Oxygenase-1 Via a Nuclear Factor-{kappa}B-Dependent Pathway Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by (2009) (0)
- An Energy Model for the Description of a Metabolic Process (1994) (0)
- Modelling Interpretation of the Kinetics of Metabolic Processes (2000) (0)
- PSUN299 GLP-1 Contribution to Insulin Secretory Response to Protein Ingestion and Insulin Kinetics Following Gastric Bypass and Sleeve Gastrectomy (2022) (0)
- P857 A NEW INDEX OF GLUTATHIONE TURNOVER (GSH_TI) AND ITS ASSOCIATION WITH SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) (2014) (0)
- P1056 : Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in patients with nonalcoholic fatty liver disease, independently of diabetes, hypertension and dyslipidemia (2015) (0)
- Interplay between metabolic derangement, biomarkers of collagen remodeling and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease (2020) (0)
- Changes in Tracer Infusion Rates to Minimize the Structure Error in the Steele’s Model (1994) (0)
- Poster session 3 (2001) (0)
- OC-36 Peripheral insulin resistance rather than hepatic is a primary defect in non obese, non diabetic, non dyslipidemic NAFLD patients: correlation with liver damage (2012) (0)
- Adding exercise to a 16-week very low calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients improves metabolic flexibility, VO 2max and mitochondrial copy number in skeletal muscle (2011) (0)
- Reduced insulin clearance relates to increased liver fat content in recent-onset type 2 diabetes and to impaired glucose control in recent-onset type 1 diabetes (2019) (0)
- 1774-P: Neurally Mediated Prandial Islet-Cell Function Is Glucose-Independent and Preserved after Gastric Bypass and Sleeve Gastrectomy (2020) (0)
- 1298-P: Metabolic Clearance of Insulin Is Altered after Gastric Bypass and Sleeve Gastrectomy (2022) (0)
- 60 Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and HCV chronic hepatitis (2004) (0)
- Dynamics of Circulating Ligands and Soluble Receptor for Advanced Glycation End-Product in Liver Transplantation: 1746 (2012) (0)
- Effect of hyperinsulinaemia on gluconeogenesis in non-diabetic subjects and in Type 2 diabetic patients. (2000) (0)
- Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease (2014) (0)
- Metabolic effects of soy supplementation in postmenopausal white and African American women: a randomized, placebo-controlled trial (2011) (0)
- High prevalence of elevated liver enzymes and glucose intolerance in morbid obese patients are reduced after laparoscopic adjustable gastric banding (LAGB) (2007) (0)
- 27th Annual Meeting of the European Group for the study of Insulin Resistance, Lisbon, Portugal, 8-9th May 2019. (2019) (0)
- Corrigendum to “Insulin resistance, adipose depots and gut: Interactions and pathological implications” [Dig. Liver Dis. 42 (2010) 310–319] (2014) (0)
- 153-OR: Glucose-Dependency of Insulinotropic and Glucagonostatic Effects of Glucagon-Like Peptide-1 after Gastric Bypass and Sleeve Gastrectomy (2020) (0)
- Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (2017) (0)
- P1042 : Deregulation of de novo lipogenesis can be associated with liver damage in patients with non alcoholic fatty liver disease (2015) (0)
- Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis (2019) (0)
- Liver damage can be associated with deregulation of the de novo lipogenesis pathway in subjects with Non Alcoholic Fatty Liver Disease (2015) (0)
- Exposure to BPA and Phthalates and Timing of Puberty in Girls (2018) (0)
- Interferon gamma-induced protein 10 levels are associated with insulin resistant components in subjects with non-alcoholic fatty liver disease (2023) (0)
- 405 REGULATION OF PLASMA FREE FATTY ACID METABOLISM DURING INTENSE EXERCISE (1994) (0)
- P849 QUANTITATIVE AND QUALITATIVE ANALYSIS OF PLASMA FREE FATTY ACIDS AND THEIR IMPACT ON LIVER DAMAGE IN NAFLD PATIENTS (2014) (0)
- SAT-323-Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease (2019) (0)
- Full Title: The Ontogeny of the Endocrine Pancreas in the Fetal/Newborn Baboon 1 (2012) (0)
- Novel hepato‐preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes (2017) (0)
- Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease (2014) (0)
- Liver transplantation is associated with an unfavorable metabolic signature (2012) (0)
- The Kruppel-like factor 6-IVS1-27A (KLF6) polymorphism is associated with more favourable postprandial glucose metabolism in subjects at high risk of type 2 diabetes (2012) (0)
- 215-LB: The Role of GLP-1 in Glycemic Response to Protein Ingestion after Gastric Bypass Surgery or Sleeve Gastrectomy (2021) (0)
- 850 PATHWAY OF PLASMA FFA OXIDATION DURING EXERCISE (1994) (0)
- Response to Comment on Gastaldelli et al. Short-term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass. Diabetes Care 2016;39:1925–1931 (2017) (0)
- Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study (2022) (0)
- Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease (2014) (0)
- 125-LB: Differential Influences of Gastric Bypass and Sleeve Gastrectomy on Glucose-Reducing Effects of DPP-4 Inhibitor (2021) (0)
- 201 Effects of GLP-1 on Glucose and Islet-Cell Secretory Responses to Protein Ingestion After Gastric Bypass or Sleeve Gastrectomy (2022) (0)
- The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF (2018) (0)
- A Leg Model of Amino Acid Kinetics in Skin and Muscle (1994) (0)
- Response to: Drug therapy for ectopic fat: myth or reality? (2017) (0)
- In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease (2018) (0)
- IDF2022-0847 Diabetogenic Effect of Gut-derived Extracellular Vesicles (2023) (0)
- Increased hepatic glucose production and insulin resistance in subjects with non-alcoholic fatty liver disease is associated to increased plasma concentrations of glucogenic amino acids (2017) (0)
- 1840-P: Pioglitazone Increases Metabolic Insulin Clearance (MCRI) in IGT Subjects: The ACT NOW Study (2019) (0)
- INHIBITION OF HEPATITIS C VIRUS TRANSLATION AND SUBGENOMIC REPLICATION BY SMALL INTERFERING RNAS DIRECTED AGAINST CELLULAR RNA BINDING PROTEINS (2004) (0)
- Metabolomic profile of morbidly obese NAFLD: effect of weight loss by exenatide or diet (2019) (0)
- Use of the tracer/tracee ratio to reduce the variability in the calculation of total energy expenditure using the doubly-labelled water method (1993) (0)
- QTc lenghtening is associated to sympathetic predominance throughout the 24 hour period in recent onset hypertension (1999) (0)
- Irisin alleviates liver oxidative stress in non-obese, non-diabetic individuals with Non-Alcoholic Fatty Liver Disease (2022) (0)
- Fatty Acid Synthase expression promotes the malignant features of cholangiocarcinoma cells and predicts shorter survival in patients (2023) (0)
- Increased gluconeogenesis in NIDDM: Substrate contribution and modulation by lipolysis (1998) (0)
- Obesity Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats (2009) (0)
- Predisposition to diabetes is related to insulin resistance in NAFLD patients and to decreased insulin secretion in HCV patients (2018) (0)
- Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity (2019) (0)
- Crosstalk between adipose tissue insulin resistance and liver macrophage activation in patients with Non-Alcoholic Fatty Liver Disease (2020) (0)
- SAT-290-Association of liver inflammation and fibrosis score with noninvasive biomarkers in non-alcoholic fatty liver disease: Preliminary results from the MAST4HEALTH study (2019) (0)
- Transforming growth factor-beta2 and thoracic aortic aneurysm (2013) (0)
- Poster Session 3 (2012) (0)
- 57-OR: Responses to Lifestyle Intervention (LI) Are Associated to the Inter-Individual Variability in Glucose Metabolism at Baseline for Individuals at High Risk of Type 2 Diabetes (T2D) (2022) (0)
- Enrichment of hepatic glycogen and plasma glucose from H₂18O informs gluconeogenic and indirect pathway fluxes in naturally feeding mice (2022) (0)
- 1264 CRITICAL ROLE OF TRIGLYCERIDES AND LONG CHAIN FATTY ACYL COA ACCUMULATION IN LIVER INSULIN RESISTANCE IN THE BABOON. A NEW NON-HUMAN PRIMATE MODEL OF NAFLD (2011) (0)
- 215 THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE) AXIS IN LIVER TRANSPLANTATION (2012) (0)
- 73 KR ÜPPEL LIKE FACTOR 6 (KLF6) PROTECTS FROM NAFLD PROGRESSION THROUGH REGULATION OF ADIPOSE TISSUE INSULIN RESISTANCE (2013) (0)
- 1836-P: Nonalcoholic Steatohepatitis (NASH) Significantly Contribute to ß-Cell Function Impairment Independently of Glucose Tolerance Status (2020) (0)
- Early increase in N(epsilon)-carboxy-methyl-lysine and decrease in sRAGE plasma values in de novo liver transplantation (2011) (0)
- High exposure to phthalates is associated with HbA1c worsening in type 2 diabetes subjects with and without edentulism: a prospective pilot study (2022) (0)
- Importance of liver fat indices for diagnosis of hepatic steatosis (2013) (0)
- Impact of short term weight loss (very low calorie diet vs bariatric surgery) on hepatic insulin resistance and plasma lipidomic profile (2018) (0)
- P845 IMPACT OF FAT VERSUS GLUCOSE LOAD ON OXIDATIVE STRESS IN NON-ALCOHOLIC FATTY LIVER DISEASE (2014) (0)
- Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic CHC patients (2009) (0)
- Role of Insulin Clearance in Insulin Action and Metabolic Diseases (2023) (0)
- A Case-Control Study of Exposure to Bisphenol-A and Phthalates in Girls with Early Onset of Puberty (2019) (0)
- Exposure to Bisphenol-A and Phtalates in Obese Girls (2018) (0)
- Insulinotropic effect of endogenous incretins is greater after gastric bypass than sleeve gastrectomy despite diminished beta-cell sensitivity to plasma incretins (2023) (0)
- O-210: Effect of a daily supplement of soy phytoestrogens on body composition and insulin secretion in postmenopausal women (2006) (0)
- The combination of mucus-degrading gram-negative bacteria and reduced antimicrobial peptides drives adipose tissue inflammation and NAFLD progression in mice lacking NLRP3-inflammasome (2017) (0)
- P0519 : Lipidomics reveals that low plasma unsaturated to saturated fat ratios are biomarkers of NAFLD and liver damage (2015) (0)
- Pathogenesis (2021) (0)
- IDF2022-0843 Hypercaloric diets impair hepatic tight junctions and lipid composition before affecting gut tight junctions (2023) (0)
- Osteoprotegerin as optimal target for the screening of patients with hepatocellular carcinoma at higher risk of mortality (2019) (0)
- Active non-alcoholic steatohepatitis and severe fibrosis are associated to dysfunctional adipose tissue and worsen with adipose tissue insulin resistance independently of body mass index (2020) (0)
- Track 9 Surgical treatment in the obese P314–P334 (2001) (0)
- Sensitivity in Obesity-Induced Diabetic Rats Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin (2009) (0)
- 1351 CONTRIBUTION OF VISCERAL FAT AND HEPATIC FAT TO METABOLIC DERANGEMENTS AND LIVER DAMAGE IN NAFLD PATIENTS (2013) (0)
- Mechanism of Action and Metabolic Effects of Exenatide in Obesity (2013) (0)
- Supplementary material : An extended fatty liver index to predict non-alcoholic fatty liver disease (2017) (0)
- Islet Cell Paracrinopathy and the Relevance of Delta-, Alpha- and Beta-Cell Dysfunction in the Development of Hyperglycemia in Non-Human Primates (2014) (0)
- Abnormal stress-induced myocardial metabolic changes in patients with dilated cardiomyopathy. (2005) (0)
- Increased gluconeogenesis in type 2 diabetes: Substrate contribution and modulation by lipolysis. (1999) (0)
- High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity (2009) (0)
- 352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Amalia Gastaldelli?
Amalia Gastaldelli is affiliated with the following schools:
